Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Organigram Global Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of OGI: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders73179+7
Shares4.26M4634.61M+350.1K (+8.2%)
Value$5.86M$611$6.08M+$218.2K (+3.7%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (17)

Institutions that held Organigram Global Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Sold out (10)

Institutions that held Organigram Global Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of OGI in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Old Mission Capital LLC97,416$128.6K
Millennium Management LLC39,788$52.8K
Capital Advisors Inc10,157$13.4K
Baker Avenue Asset Management, LP1,165$1.54K
Beaird Harris Wealth Management, LLC460$608
Rise Advisors, LLC277$366
WR Wealth Planners, LLC12$16
Nemes Rush Group LLC2$3
NBC Securities, Inc.500$0
CWM, LLC62$0

Not filed for Q4 2023 yet (1)

Institutions that held Organigram Global Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Johnson Midwest Financial, LLC463$611